NMTR

9 Meters Biopharma, Inc. Common Stock
NMTR

Delisted

NMTR was delisted on the 25th of July, 2023.

Back to rankings
 

About: 9 Meters Biopharma Inc is a clinical-stage biopharmaceutical company focused on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. Its products include NM-002, Larazotide, NM-003, and others.

Employees: 10

Healthcare Drug Manufacturers - General
Charts implemented using Lightweight Charts™